Compare Definium Therapeutics Inc. Common Shares (DFTX) vs SYSCO Corporation (SYY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs SYSCO Corporation — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while SYSCO Corporation trades at $78.07 (market cap $37.77B). The key difference: SYSCO Corporation is far larger — about 8× Definium Therapeutics Inc. Common Shares's market cap, and SYSCO Corporation pays a 2.86% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and SYSCO Corporation for 77 Days on average.
| DFTX | SYY | |
|---|---|---|
Market Cap | $4.71B | $37.77B |
Volume | 1,966,636 | 2,255,547 |
Sector | Health | Consumer Staples |
52-Week High | $48.45 | $91.16 |
52-Week Low | $10.68 | $69.30 |
Typical Hold Time | 0 Days | 77 Days |
Enterprise Value | $3.67B | $50.96B |
Dividend Yield | — | 2.86% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SYY trades at $78.20, up 0.97% today, with a bearish technical signal from moving averages. Revenue grew to $81.37B in 2025, though net income margin softened to 2.08%. The company recently announced a $500M AI efficiency program and closed a $1.5B senior notes offering (GlobeNewsWire, 2026-09-25). Analyst consensus is bullish with a $85.75 price target, and the stock offers a dividend with an upcoming $0.55 payment.
Outlook remains supported by growth targets and cost-saving initiatives, but risks include high debt levels and margin pressure. The stock presents a value opportunity with a low P/S ratio of 0.44, though investors face volatility from recent equity dilution and macroeconomic sensitivity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About SYSCO Corporation
Sysco is the largest U.S. food-service distributor, boasting 17% market share of the highly fragmented food-service distribution industry. Sysco distributes over 400,000 food and nonfood products to restaurants (63% of revenue), healthcare facilities (8%), education and government buildings (8%), travel and leisure (7%), and other locations (14%) where individuals consume away-from-home meals. In fiscal 2022, 82% of the firm's revenue was U.S.-based, with 7% from Canada, 4% from the U.K., 2% from France, and 4% other.
Read more on SYY →
